- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
|International Nonproprietary Names|
|RG7155 | RO5509554|
|Emactuzumab is a humanized, IgG1κ anti-colony stimulating factor 1 receptor (CSF1R) monoclonal antibody, being investigated for its anti-cancer potential.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record.
Peptide sequence analysis using the heavy and light chain variable regions of emactuzumab reveals 100% matches to sequences 39 and 40 respectively from patent US20110165156 . These two sequences belong to the clone named hMab 2F11-e7 (or simply 2F11) in the patent document.
|GtoPdb PubChem SID||310264725|
|Search PubMed clinical trials||emactuzumab|
|Search PubMed titles||emactuzumab|
|Search PubMed titles/abstracts||emactuzumab|